Is Apple Stock Undervalued or Overvalued?
For many years, Apple (NASDAQ:AAPL) was just about the perfect…
Sell
49
COO Quote, Financials, Valuation and Earnings
Last price:
$80.11
Seasonality move
:
1.22%
Day range:
$79.62 - $80.95
52-week range:
$69.81 - $112.38
Dividend yield:
0%
P/E ratio:
39.12x
P/S ratio:
4.12x
P/B ratio:
1.98x
Volume:
2.7M
Avg. volume:
1.7M
1-year change:
-15.07%
Market cap:
$16.1B
Revenue:
$3.9B
EPS (TTM):
$2.06
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
COO
The Cooper Companies
|
$995.2M | $0.93 | 6.45% | 101.81% | $105.55 |
|
BSX
Boston Scientific
|
$4.6B | $0.67 | 18.78% | 229.2% | $116.96 |
|
KIDS
OrthoPediatrics
|
$51.7M | -$0.44 | 16.28% | -7.69% | $36.43 |
|
LUCY
Innovative Eyewear
|
$1M | -$0.73 | 223.96% | -58.82% | $7.00 |
|
NXGL
NexGel
|
$2.7M | -$0.10 | 113.89% | -50% | $6.00 |
|
STAA
Staar Surgical
|
$40.3M | -$0.60 | -58.72% | -760% | $19.10 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
COO
The Cooper Companies
|
$80.59 | $105.55 | $16.1B | 39.12x | $0.01 | 0% | 4.12x |
|
BSX
Boston Scientific
|
$106.17 | $116.96 | $157.1B | 77.50x | $0.00 | 0% | 9.00x |
|
KIDS
OrthoPediatrics
|
$21.12 | $36.43 | $523.1M | -- | $0.00 | 0% | 2.30x |
|
LUCY
Innovative Eyewear
|
$2.85 | $7.00 | $8.8M | -- | $0.00 | 0% | 3.21x |
|
NXGL
NexGel
|
$2.18 | $6.00 | $16.7M | -- | $0.00 | 0% | 1.48x |
|
STAA
Staar Surgical
|
$18.92 | $19.10 | $937M | 49.73x | $0.00 | 0% | 3.36x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
COO
The Cooper Companies
|
23.79% | 1.269 | 13.14% | 0.82x |
|
BSX
Boston Scientific
|
33.49% | 1.029 | 7.48% | 0.68x |
|
KIDS
OrthoPediatrics
|
17.41% | 0.190 | 11.97% | 2.74x |
|
LUCY
Innovative Eyewear
|
-- | 13.762 | -- | 11.96x |
|
NXGL
NexGel
|
11.28% | -0.457 | 2.86% | 0.84x |
|
STAA
Staar Surgical
|
-- | 1.124 | -- | 3.88x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
COO
The Cooper Companies
|
$660.2M | $182M | 3.93% | 5.24% | 18.59% | $101.2M |
|
BSX
Boston Scientific
|
$3.2B | $937M | 6.35% | 9.57% | 19.02% | $277M |
|
KIDS
OrthoPediatrics
|
$38.3M | -$10.9M | -9.9% | -11.21% | -17.82% | -$8.4M |
|
LUCY
Innovative Eyewear
|
$220.5K | -$1.9M | -97.69% | -97.69% | -418.88% | -$2.4M |
|
NXGL
NexGel
|
$1.2M | -$777K | -51.9% | -59.55% | -23.41% | -$400K |
|
STAA
Staar Surgical
|
$28M | -$34.7M | -17.97% | -17.97% | -81.56% | -$7.2M |
The Cooper Companies vs. Competitors
-
Which has Higher Returns COO or BSX?
Boston Scientific has a net margin of 10.81% compared to The Cooper Companies's net margin of 14.45%. The Cooper Companies's return on equity of 5.24% beat Boston Scientific's return on equity of 9.57%.
Company Gross Margin Earnings Per Share Invested Capital COOThe Cooper Companies68.44% $0.52 $10.7B BSXBoston Scientific68.84% $0.45 $33.6B -
What do Analysts Say About COO or BSX?
The Cooper Companies has a consensus price target of $105.55, signalling upside risk potential of 30.98%. On the other hand Boston Scientific has an analysts' consensus of $116.96 which suggests that it could grow by 10.17%. Given that The Cooper Companies has higher upside potential than Boston Scientific, analysts believe The Cooper Companies is more attractive than Boston Scientific.
Company Buy Ratings Hold Ratings Sell Ratings COOThe Cooper Companies9 7 0 BSXBoston Scientific23 3 0 -
Is COO or BSX More Risky?
The Cooper Companies has a beta of 1.081, which suggesting that the stock is 8.103% more volatile than S&P 500. In comparison Boston Scientific has a beta of 0.685, suggesting its less volatile than the S&P 500 by 31.536%.
-
Which is a Better Dividend Stock COO or BSX?
The Cooper Companies has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Boston Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Companies pays -- of its earnings as a dividend. Boston Scientific pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COO or BSX?
The Cooper Companies quarterly revenues are $964.7M, which are smaller than Boston Scientific quarterly revenues of $4.7B. The Cooper Companies's net income of $104.3M is lower than Boston Scientific's net income of $674M. Notably, The Cooper Companies's price-to-earnings ratio is 39.12x while Boston Scientific's PE ratio is 77.50x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Companies is 4.12x versus 9.00x for Boston Scientific. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COOThe Cooper Companies4.12x 39.12x $964.7M $104.3M BSXBoston Scientific9.00x 77.50x $4.7B $674M
-
Which has Higher Returns COO or KIDS?
OrthoPediatrics has a net margin of 10.81% compared to The Cooper Companies's net margin of -20.34%. The Cooper Companies's return on equity of 5.24% beat OrthoPediatrics's return on equity of -11.21%.
Company Gross Margin Earnings Per Share Invested Capital COOThe Cooper Companies68.44% $0.52 $10.7B KIDSOrthoPediatrics73% -$0.46 $420.3M -
What do Analysts Say About COO or KIDS?
The Cooper Companies has a consensus price target of $105.55, signalling upside risk potential of 30.98%. On the other hand OrthoPediatrics has an analysts' consensus of $36.43 which suggests that it could grow by 72.48%. Given that OrthoPediatrics has higher upside potential than The Cooper Companies, analysts believe OrthoPediatrics is more attractive than The Cooper Companies.
Company Buy Ratings Hold Ratings Sell Ratings COOThe Cooper Companies9 7 0 KIDSOrthoPediatrics3 1 0 -
Is COO or KIDS More Risky?
The Cooper Companies has a beta of 1.081, which suggesting that the stock is 8.103% more volatile than S&P 500. In comparison OrthoPediatrics has a beta of 1.095, suggesting its more volatile than the S&P 500 by 9.463%.
-
Which is a Better Dividend Stock COO or KIDS?
The Cooper Companies has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. OrthoPediatrics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Companies pays -- of its earnings as a dividend. OrthoPediatrics pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COO or KIDS?
The Cooper Companies quarterly revenues are $964.7M, which are larger than OrthoPediatrics quarterly revenues of $52.4M. The Cooper Companies's net income of $104.3M is higher than OrthoPediatrics's net income of -$10.7M. Notably, The Cooper Companies's price-to-earnings ratio is 39.12x while OrthoPediatrics's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Companies is 4.12x versus 2.30x for OrthoPediatrics. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COOThe Cooper Companies4.12x 39.12x $964.7M $104.3M KIDSOrthoPediatrics2.30x -- $52.4M -$10.7M
-
Which has Higher Returns COO or LUCY?
Innovative Eyewear has a net margin of 10.81% compared to The Cooper Companies's net margin of -391.35%. The Cooper Companies's return on equity of 5.24% beat Innovative Eyewear's return on equity of -97.69%.
Company Gross Margin Earnings Per Share Invested Capital COOThe Cooper Companies68.44% $0.52 $10.7B LUCYInnovative Eyewear48.52% -$0.72 $7.5M -
What do Analysts Say About COO or LUCY?
The Cooper Companies has a consensus price target of $105.55, signalling upside risk potential of 30.98%. On the other hand Innovative Eyewear has an analysts' consensus of $7.00 which suggests that it could grow by 145.61%. Given that Innovative Eyewear has higher upside potential than The Cooper Companies, analysts believe Innovative Eyewear is more attractive than The Cooper Companies.
Company Buy Ratings Hold Ratings Sell Ratings COOThe Cooper Companies9 7 0 LUCYInnovative Eyewear0 0 0 -
Is COO or LUCY More Risky?
The Cooper Companies has a beta of 1.081, which suggesting that the stock is 8.103% more volatile than S&P 500. In comparison Innovative Eyewear has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock COO or LUCY?
The Cooper Companies has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Innovative Eyewear offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Companies pays -- of its earnings as a dividend. Innovative Eyewear pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COO or LUCY?
The Cooper Companies quarterly revenues are $964.7M, which are larger than Innovative Eyewear quarterly revenues of $454.5K. The Cooper Companies's net income of $104.3M is higher than Innovative Eyewear's net income of -$1.8M. Notably, The Cooper Companies's price-to-earnings ratio is 39.12x while Innovative Eyewear's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Companies is 4.12x versus 3.21x for Innovative Eyewear. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COOThe Cooper Companies4.12x 39.12x $964.7M $104.3M LUCYInnovative Eyewear3.21x -- $454.5K -$1.8M
-
Which has Higher Returns COO or NXGL?
NexGel has a net margin of 10.81% compared to The Cooper Companies's net margin of -25.37%. The Cooper Companies's return on equity of 5.24% beat NexGel's return on equity of -59.55%.
Company Gross Margin Earnings Per Share Invested Capital COOThe Cooper Companies68.44% $0.52 $10.7B NXGLNexGel42.34% -$0.09 $6.2M -
What do Analysts Say About COO or NXGL?
The Cooper Companies has a consensus price target of $105.55, signalling upside risk potential of 30.98%. On the other hand NexGel has an analysts' consensus of $6.00 which suggests that it could grow by 175.23%. Given that NexGel has higher upside potential than The Cooper Companies, analysts believe NexGel is more attractive than The Cooper Companies.
Company Buy Ratings Hold Ratings Sell Ratings COOThe Cooper Companies9 7 0 NXGLNexGel0 0 0 -
Is COO or NXGL More Risky?
The Cooper Companies has a beta of 1.081, which suggesting that the stock is 8.103% more volatile than S&P 500. In comparison NexGel has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock COO or NXGL?
The Cooper Companies has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. NexGel offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Companies pays -- of its earnings as a dividend. NexGel pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COO or NXGL?
The Cooper Companies quarterly revenues are $964.7M, which are larger than NexGel quarterly revenues of $2.8M. The Cooper Companies's net income of $104.3M is higher than NexGel's net income of -$712K. Notably, The Cooper Companies's price-to-earnings ratio is 39.12x while NexGel's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Companies is 4.12x versus 1.48x for NexGel. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COOThe Cooper Companies4.12x 39.12x $964.7M $104.3M NXGLNexGel1.48x -- $2.8M -$712K
-
Which has Higher Returns COO or STAA?
Staar Surgical has a net margin of 10.81% compared to The Cooper Companies's net margin of -127.29%. The Cooper Companies's return on equity of 5.24% beat Staar Surgical's return on equity of -17.97%.
Company Gross Margin Earnings Per Share Invested Capital COOThe Cooper Companies68.44% $0.52 $10.7B STAAStaar Surgical65.76% -$1.10 $350M -
What do Analysts Say About COO or STAA?
The Cooper Companies has a consensus price target of $105.55, signalling upside risk potential of 30.98%. On the other hand Staar Surgical has an analysts' consensus of $19.10 which suggests that it could grow by 0.95%. Given that The Cooper Companies has higher upside potential than Staar Surgical, analysts believe The Cooper Companies is more attractive than Staar Surgical.
Company Buy Ratings Hold Ratings Sell Ratings COOThe Cooper Companies9 7 0 STAAStaar Surgical3 10 1 -
Is COO or STAA More Risky?
The Cooper Companies has a beta of 1.081, which suggesting that the stock is 8.103% more volatile than S&P 500. In comparison Staar Surgical has a beta of 0.652, suggesting its less volatile than the S&P 500 by 34.797%.
-
Which is a Better Dividend Stock COO or STAA?
The Cooper Companies has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Staar Surgical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Companies pays -- of its earnings as a dividend. Staar Surgical pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COO or STAA?
The Cooper Companies quarterly revenues are $964.7M, which are larger than Staar Surgical quarterly revenues of $42.6M. The Cooper Companies's net income of $104.3M is higher than Staar Surgical's net income of -$54.2M. Notably, The Cooper Companies's price-to-earnings ratio is 39.12x while Staar Surgical's PE ratio is 49.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Companies is 4.12x versus 3.36x for Staar Surgical. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COOThe Cooper Companies4.12x 39.12x $964.7M $104.3M STAAStaar Surgical3.36x 49.73x $42.6M -$54.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Palo Alto Networks Stock Be in 5 Years?
You know those companies that just refuse to slow down…
UPS Stock Forecast: Is the 6.9% Dividend Too Good to Be True?
Parcel delivery giant UPS (NYSE:UPS) has seen its fair share…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
68
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
58
TNXP alert for May 28
Tonix Pharmaceuticals Holding [TNXP] is up 1.57% over the past day.
Sell
37
ATS alert for May 28
ATS [ATS] is down 1.27% over the past day.
Buy
88
SMR alert for May 28
NuScale Power [SMR] is down 0.37% over the past day.
